Impaired awareness of hypoglycemia (IAH), defined as an attenuated or absent ability to recognize the signs of low blood sugar, can be a serious and life-threatening condition for patients living with type 1 diabetes (T1D). Fortunately, research and technological advancements have yielded new opportunities to improve outcomes and quality of life in these patients, including new and emerging cell-based therapies for restoring endogenous insulin production. Watch this video to hear leading clinical experts share their strategies for proactively identifying patients with IAH and discuss the latest evidence surrounding new and emerging treatments. Don’t miss the opportunity to: Hear practical strategies for identifying patients with IAH in your own clinical practice Learn about the latest therapeutic approaches for T1D, including new and emerging cell-based therapies, which will be illustrated through video animation Stay up to date on the latest clinical evidence for emerging treatment approaches to restore endogenous insulin production in patients with T1D
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/cutting-edge-treatment-approaches-patients-t1d-impaired-awareness-hypoglycemia
- Start Date: 2024-02-21 06:00:00
- End Date: 2024-02-21 06:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Vertex Pharmaceuticals Incorporated - Amount: 33166.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all